US PTAB IP Litigation

patent denied · Oct 5, 2024

Microsoft and EyesMatch settled the IPR over patent 8,982,110 B2, leading the Board to terminate the proceeding and seal the settlement agreement as confidential business information.

patent · Oct 5, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00890

Abbott Diabetes Care and DexCom jointly filed a request to have their settlement agreement treated as business‑confidential, invoking 35 U.S.C. §317(b) and related regulations.

AMAZON.COM, INC. et al. v.Nokia Technologies Oy

· IPR2024-00847

The PTAB denied Amazon's request for Director Review of the institution decision in IPR2024-00847, leaving the institution of Nokia's patent 7,532,808 in place.

patent denied · Oct 5, 2024

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

patent terminated or settled · Oct 5, 2024

The USPTO Director denied Google’s request for Director Review of the Final Written Decision in IPR2024-00810 concerning EyesMatch’s eye‑recognition patent.

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

Samsung and EyesMatch settled the IPR over patent 8,982,110, leading the Board to terminate the proceeding for Samsung and seal the settlement agreement as confidential business information.

patent · Oct 5, 2024

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

Samsung and EyesMatch have filed a joint motion asking the PTAB to keep their settlement agreement confidential under statutory provisions. The request cites 35 U.S.C. §327 and related CFR rules.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00891

Petitioner Abbott Diabetes Care Inc. challenges DexCom's '031 patent claims 23-46 in an IPR proceeding. The challenge asserts that the core inventive feature—using a priori information regarding sensor drift profiles—is anticipated or rendered obvious by prior art references Zhang and Shin.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00890

Abbott Diabetes Care Inc. has filed a petition challenging DexCom’s '031 patent related to Continuous Glucose Monitoring (CGM) technology. The challenge asserts that the core inventive feature—using prior information to manage sensor sensitivity drift—is anticipated or rendered obvious by existing prior art references, Zhang and Shin.

patent · Oct 5, 2024

AMAZON.COM, INC. et al. v.Nokia Technologies Oy

· IPR2024-00848

Amazon has filed an IPR petition challenging Nokia's '808 patent, asserting that its skip coding mode is obvious over existing prior art references. The challenge focuses on whether combining zero-motion vector (ZMV) and non-zero motion vector (PNZMV) modes constitutes a predictable combination of known techniques in video compression. This dispute involves complex technical arguments regarding standard-setting technologies.

AMAZON.COM, INC. et al. v.Nokia Technologies Oy

· IPR2024-00847

Amazon has filed a petition challenging Nokia's video compression patent (7,532,808) at the PTAB. The petitioner asserts that the challenged claims are obvious under Section 103 over prior art references including Karczewicz, Frojdh, and H.263. This action targets core technology related to motion estimation and coding.

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

Samsung filed a petition challenging EyesMatch's patent claims related to virtual mirrors and image processing, asserting obviousness under 35 U.S.C. § 103. The challenge relies on combining various prior art references (e.g., Haan/Francois, Geisner/Lizee) to demonstrate that the claimed technology was predictable.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00891

Abbott Diabetes Care Inc. successfully secured institutional status in an IPR against DexCom, Inc., regarding continuous glucose monitoring systems. The Board found sufficient evidence that prior art references anticipate or render obvious key claims related to transcutaneous sensors and drift profiles.

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00890

Abbott Diabetes Care Inc. successfully petitioned to institute IPR against DexCom, Inc.'s glucose monitoring patent (11020031). The Board found sufficient evidence for trial on 22 claims based on anticipation and obviousness over prior art from Zhang and Shin.

AMAZON.COM, INC. et al. v.Nokia Technologies Oy

· IPR2024-00848

The PTAB instituted the IPR, finding a reasonable likelihood of unpatentability for claims related to video compression and coding. The Board found that prior art references like Karczewicz and Frojdh, combined with H.263 standards, teach the claimed 'skip coding mode.'

AMAZON.COM, INC. et al. v.Nokia Technologies Oy

· IPR2024-00847

Amazon challenged Nokia's video coding patent (7532808) at the PTAB, arguing that the claims are obvious over prior art references like Karczewicz and Frojdh. The Board found a reasonable likelihood of unpatentability for several claims, supporting Amazon’s position on key skip coding mode limitations.

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

patent Final Written Decision · Oct 5, 2024

Samsung Electronics Co., Ltd. successfully petitioned to challenge EyesMatch Ltd.'s patent on virtual mirror/interactive display technology. The PTAB institution decision found a reasonable likelihood of prevailing regarding claim 1, initiating an IPR proceeding against the core claims (1-18).

Samsung Electronics Co., Ltd. et al. v.EyesMatch Ltd.

The PTAB issued a Final Written Decision finding all 18 challenged claims unpatentable over prior art combinations. The Board adopted the District Court's construction of 'mirror tracking mode,' which requires the user to see a reversed reflection at roughly double the distance while maintaining constant size. This decision involved complex obviousness arguments regarding adaptive transformation mapping.

Texas Instruments Incorporated v.Greenthread, LLC

· IPR2024-00773

The USPTO denied Texas Instruments' request for Director Review of the Final Written Decisions in two IPRs involving a Greenthread patent on power management circuitry.

Texas Instruments Incorporated v.Greenthread, LLC

· IPR2024-00771

The USPTO denied Texas Instruments' request for Director Review of the Final Written Decisions in two IPRs involving Greenthread's image‑sensor patent, leaving the original rulings intact.

patent · Oct 4, 2024

BTL Industries, Inc. v.InMode Ltd.

· IPR2024-00703

ThermiGen settled its patent infringement lawsuit with Viveve Medical, securing a non‑exclusive license and agreeing to pay royalties. The settlement resolves the 2016 litigation and allows Thermi to continue developing its temperature‑controlled RF platforms for women's intimate health.

Texas Instruments Incorporated v.Greenthread, LLC

· IPR2024-00772

The USPTO denied Texas Instruments’ request for Director Review of the Final Written Decisions in several IPRs involving Greenthread’s patent 10,734,481. The Board found no basis to overturn the earlier rulings.